首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer
【24h】

MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer

机译:MicroRNA-148b通过靶向大肠癌中的胆囊收缩素2受体抑制细胞生长

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

MicroRNAs (miRNAs) play an important role in the regulation of a variety of cellular processes, including cell growth, differentiation, apoptosis and carcinogenesis. The purpose of this study was to elucidate the molecular mechanisms by which miR-148b acts as a tumor suppressor in colorectal cancer. The expression of miR-148b was significantly downregulated in 96 pairs of human colorectal cancer tissues (p < 0.0001) and three cell lines (p < 0.01) compared with non-tumor adjacent tissues by quantitative real-time PCR. The results of in situ hybridization highlighted that miR-148b was important in the cancer transformation process. Using statistical analysis, we found that the expression level of miR-148b was associated with tumor size (p = 0.033) in colorectal cancer patients. Moreover, overexpression of miR-148b in HCT-116 and HT-29 cells could inhibit cell proliferation in vitro and suppress tumorigenicity in vivo. Importantly, the result of luciferase activity assay and western blot showed that the cholecystokinin-2 receptor gene (CCK2R) was a target of miR-148b and was downregulated by miR-148b at the translational level. Then, we used siRNA, radioimmunoassay and ELISA to demonstrate that miR-148b might have an effect on cell proliferation by regulating the expression of CCK2R which functioned depending on the gastrin in colorectal cancer. Taken together, our data provides the first evidences that miR-148b acts as a tumor suppressor in colorectal cancer and should be further evaluated as a biomarker and therapeutic tool against colorectal cancer.
机译:MicroRNA(miRNA)在多种细胞过程的调控中起着重要作用,包括细胞生长,分化,凋亡和致癌作用。这项研究的目的是阐明miR-148b在大肠癌中起抑癌作用的分子机制。通过定量实时PCR,与非肿瘤邻近组织相比,miR-148b的表达在96对人类结直肠癌组织(p <0.0001)和三种细胞系(p <0.01)中显着下调。原位杂交的结果表明,miR-148b在癌症转化过程中很重要。使用统计分析,我们发现miR-148b的表达水平与大肠癌患者的肿瘤大小相关(p = 0.033)。此外,miR-148b在HCT-116和HT-29细胞中的过表达可在体外抑制细胞增殖并在体内抑制致瘤性。重要的是,荧光素酶活性测定和蛋白质印迹的结果表明,胆囊收缩素2受体基因(CCK2R)是miR-148b的靶标,并且在翻译水平上被miR-148b下调。然后,我们使用siRNA,放射免疫分析和ELISA来证明miR-148b可能通过调节CCK2R的表达来影响细胞增殖,CCK2R的表达依赖于大肠癌中胃泌素的功能。综上所述,我们的数据提供了第一个证据,证明miR-148b在大肠癌中起着抑癌作用,应进一步评估其作为抗大肠癌的生物标志物和治疗工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号